ArticleClinicoEconomics and outcomes research : CEOR2016

A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.

Josep Darbà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.